ROR1 ADC: AxcynDOTM Dual Payload Plaftorm

By | 25 February 2026

Outlining a dual-payload ADC platform for next-generation therapeutics
Discovering anti-ROR1 ADC candidates
Sharing a preclinical evaluation supporting enhanced anti-tumor activity and overcoming resistance